Authors' Reply: Proton Pump Inhibitors May Cause a Decline in eGFR by Inhibiting Organic Cation Transporter 2-Dependent Creatinine Secretion.
作者信息
Pyne Lonnie, Eikelboom John, Bosch Jacqueline, Walsh Michael
机构信息
The Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.
Division of Nephrology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
出版信息
J Am Soc Nephrol. 2024 Nov 1;35(11):1614. doi: 10.1681/ASN.0000000000000464. Epub 2024 Aug 19.
Abstract
摘要
相似文献
1
Authors' Reply: Proton Pump Inhibitors May Cause a Decline in eGFR by Inhibiting Organic Cation Transporter 2-Dependent Creatinine Secretion.作者回复：质子泵抑制剂可能通过抑制有机阳离子转运体2依赖性肌酐分泌导致估算肾小球滤过率下降。
J Am Soc Nephrol. 2024 Nov 1;35(11):1614. doi: 10.1681/ASN.0000000000000464. Epub 2024 Aug 19.
2
Proton Pump Inhibitors May Cause a Decline in eGFR by Inhibiting Organic Cation Transporter 2-Dependent Creatinine Secretion.质子泵抑制剂可能通过抑制有机阳离子转运体2依赖的肌酐分泌导致估算肾小球滤过率下降。
J Am Soc Nephrol. 2024 Nov 1;35(11):1613. doi: 10.1681/ASN.0000000000000463. Epub 2024 Aug 19.
3
Proton pump inhibitors for the prevention of non-steroidal anti-inflammatory drug-induced ulcers and dyspepsia.质子泵抑制剂用于预防非甾体抗炎药引起的溃疡和消化不良。
Cochrane Database Syst Rev. 2025 May 8;5(5):CD014585. doi: 10.1002/14651858.CD014585.pub2.
4
Interplay of Chronic Kidney Disease and the Effects of Tirzepatide in Patients With Heart Failure, Preserved Ejection Fraction, and Obesity: The SUMMIT Trial.慢性肾脏病与替尔泊肽对射血分数保留的肥胖心力衰竭患者的影响：SUMMIT试验
J Am Coll Cardiol. 2025 May 13;85(18):1721-1735. doi: 10.1016/j.jacc.2025.03.009. Epub 2025 Mar 31.
5
Lansoprazole identified as a prophylactic agent for oxaliplatin-induced peripheral neuropathy using integrated in silico, in vitro, and in vivo analyses.通过整合计算机模拟、体外和体内分析，兰索拉唑被确定为奥沙利铂诱导的周围神经病变的预防药物。
Biomed Pharmacother. 2025 Aug;189:118272. doi: 10.1016/j.biopha.2025.118272. Epub 2025 Jun 16.
6
Proton pump inhibitors for functional dyspepsia.用于功能性消化不良的质子泵抑制剂。
Cochrane Database Syst Rev. 2017 Nov 21;11(11):CD011194. doi: 10.1002/14651858.CD011194.pub3.
7
Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.用于治疗糖尿病和慢性肾脏病患者的胰岛素及降糖药物。
Cochrane Database Syst Rev. 2018 Sep 24;9(9):CD011798. doi: 10.1002/14651858.CD011798.pub2.
8
The clinical and economic impact of competing management strategies for gastro-oesophageal reflux disease.胃食管反流病不同管理策略的临床和经济影响
Aliment Pharmacol Ther. 2002 Feb;16(2):261-73. doi: 10.1046/j.1365-2036.2002.01167.x.
9
Deprescribing versus continuation of chronic proton pump inhibitor use in adults.成人慢性质子泵抑制剂的撤药与继续用药对比
Cochrane Database Syst Rev. 2017 Mar 16;3(3):CD011969. doi: 10.1002/14651858.CD011969.pub2.
10
Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units.重症监护病房患者上消化道出血的预防干预措施。
Cochrane Database Syst Rev. 2018 Jun 4;6(6):CD008687. doi: 10.1002/14651858.CD008687.pub2.
本文引用的文献
1
Proton Pump Inhibitors May Cause a Decline in eGFR by Inhibiting Organic Cation Transporter 2-Dependent Creatinine Secretion.质子泵抑制剂可能通过抑制有机阳离子转运体2依赖的肌酐分泌导致估算肾小球滤过率下降。
J Am Soc Nephrol. 2024 Nov 1;35(11):1613. doi: 10.1681/ASN.0000000000000463. Epub 2024 Aug 19.
2
The Effects of Pantoprazole on Kidney Outcomes: Post Hoc Observational Analysis from the COMPASS Trial.泮托拉唑对肾脏结局的影响：COMPASS试验的事后观察性分析。
J Am Soc Nephrol. 2024 Jul 1;35(7):901-909. doi: 10.1681/ASN.0000000000000356. Epub 2024 Apr 11.
3
Substrate-Dependent Inhibition of the Human Organic Cation Transporter OCT2: A Comparison of Metformin with Experimental Substrates.人有机阳离子转运体OCT2的底物依赖性抑制：二甲双胍与实验性底物的比较
PLoS One. 2015 Sep 1;10(9):e0136451. doi: 10.1371/journal.pone.0136451. eCollection 2015.
4
Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs).质子泵抑制剂抑制有机阳离子转运体（OCTs）摄取二甲双胍。
PLoS One. 2011;6(7):e22163. doi: 10.1371/journal.pone.0022163. Epub 2011 Jul 14.
Zotero 插件